103323-29-1

Basic information

• Product Name: 1-Butanone, 1-(3-hydroxyphenyl)-
• CAS NO: 103323-29-1
• Molecular Formula: C10H12O2
• Molecular Weight: 164.204
• Mol File: 103323-29-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-Butanone, 1-(3-hydroxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Butanone, 1-(3-hydroxyphenyl)-(103323-29-1)
• EPA Substance Registry System: 1-Butanone, 1-(3-hydroxyphenyl)-(103323-29-1)

Safety Data

• Hazardous Substances Data: 103323-29-1(Hazardous Substances Data)

Upstream product

• 100-83-4 meta-hydroxybenzaldehyde 
• 134154-43-1 1-hydroxy-1-(3-hydroxyphenyl)butane 
• 21999-97-3 m-Acetoxy-butyrophenon 

Downstream Products

• 107821-11-4 (2-ethyl-5-butyl-phenoxy)-acetic acid 
• 107821-37-4 (4-ethyl-3-butyl-phenoxy)-acetic acid 
• 105337-19-7 4'-butyl-2'-hydroxyacetophenone 
• 105337-80-2 1-(2-butyl-4-hydroxy-phenyl)-ethanone 
• 107055-23-2 4-ethyl-3-butyl-phenol 
• 1878-53-1 (3-butyl-phenoxy)-acetic acid 
• 72386-21-1 2-ethyl-5-n-butylphenol 
• 103034-09-9 1-(3-benzyloxy-phenyl)-2-(1-methyl-3-phenyl-propylamino)-butan-1-one; hydrochloride 
• 107683-72-7 1-(3-hydroxy-phenyl)-2-phenethylamino-butan-1-ol; hydrochloride 
• 134154-08-8 2-{1-Methoxy-1-[3-(naphthalen-2-ylmethoxy)-phenyl]-butyl}-thiazole 
• 134177-76-7 1-[3-(Naphthalen-2-ylmethoxy)-phenyl]-1-thiazol-2-yl-butan-1-ol 
• 134154-54-4 1-<3-(naphth-2-ylmethoxy)phenyl>butan-1-one 
• 101594-57-4 1-(3-benzyloxy-phenyl)-butan-1-one 
• 4074-43-5 m-butyl phenol 

Relevant articles and documents

CHEMICAL COMPOUNDS

The present invention discloses to novel compounds with a variety of therapeutic uses. More particularly, the invention discloses novel symmetrical triphenyl compounds that are particularly useful for selective estrogen receptor modulation.

5-LIPOXYGENASE INHIBITORY THIAZOLES

The invention concerns a thiazole of the formula I, wherein Ar1 is optionally substituted aryl of up to 10 carbon atoms; A is a direct link to X, or is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo(3-6C)alkylene; X is oxy, thio, sulphinyl, sulphonyl or imino; Ar2 is optionally substituted phenylene, or a 6-membered heterocyclene moiety containing up to three nitrogen atoms; R1 is hydrogen, (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl or substituted (1-4C)alkyl; R2 is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, substituted (1-4C)alkyl or (2-6C)alkanoyl; Q is optionally substituted thiazolyl; or a pharmaceutically-acceptable salt thereof. The invention also concerns processes for the manufacture of a thiazole of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said thiazole

BETA-ADRENERGIC BLOCKING AGENTS IN THE 1,2,3-THIADIAZOLE SERIES

Novel 4-2,3 or 4(3-amino-2-hydroxypropoxy) phenyl!-and 5-2, 3 or 4(3-amino-2-hydroxypropoxy) phenyl!-1,2,3-thiadiazole derivatives which may be further substituted at the C-5 or C-4 position of the thiadiazole ring, respectively, by a lower alkyl, phenyl, trifluoromethyl, carboxy, alkoxycarbonyl, cyano or an aminocarbonyl group, and the pharmaceutically acceptable acid addition salts thereof and processes for the production of such compounds; 4-4(3-t-butylamino-2-hydroxypropoxy) phenyl!-1,2,3-thiadiazole and 5-4(3-t-butylamino-2-hydroxypropoxy) phenyl!-1,2,3-thiadiazole are representative of the class. These compounds possess cardiovascular activity and are useful for the treatment of abnormal heart conditions in mammals.